Literature DB >> 11906551

Omentectomy, peritoneal biopsy and appendectomy in patients with clinical stage I endometrial carcinoma.

U Saygili1, S Kavaz, S Altunyurt, T Uslu, M Koyuncuoglu, O Erten.   

Abstract

The aim of this study was to evaluate whether omentectomy, appendectomy, and peritoneal biopsy should be a routine part of staging surgery in endometrial carcinoma. Data of 97 patients who had been diagnosed with clinical stage I endometrial carcinoma were reviewed. Associations in the data obtained, pelvic and para-aortic lymph node status, depth of myometrial invasion, grade, and histology were investigated. The chi-square (chi2) test was used for statistical analysis. Of 97 patients, six (6%) had omental metastases, which was microscopic in four. There was a statistically significant relationship between omental metastasis and tumor grade (P < 0.01). Deep myometrial invasion was significantly more common in patients with omental metastases. Tumor was found in one of 55 appendectomy specimens (2%). Omentectomy may be included in surgical staging in patients with deeply invasive or grade 3 endometrial cancer because of the possibility of omental metastasis in spite of what appears to be stage I disease in laparotomy. In other cases, omentectomy and appendectomy and biopsies from peritoneal sites should be performed in the presence of grossly suspicious disease.

Entities:  

Mesh:

Year:  2001        PMID: 11906551     DOI: 10.1046/j.1525-1438.2001.01065.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  4 in total

1.  What is the importance of omental metastasis in patients with endometrial cancer?

Authors:  Taner Turan; Işın Ureyen; Alper Karalök; Tolga Taşçı; Hilal Ilgın; Levent Keskin; M Faruk Kose; Gökhan Tulunay
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

2.  The role of omentectomy during the surgical staging in patients with clinical stage I endometrioid adenocarcinoma.

Authors:  Jale Metindir; Gülay Bilir Dilek
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-02       Impact factor: 4.553

3.  Surgical management of non-invasive uterine clear cell carcinoma.

Authors:  Toru Sugiyama; Satoshi Takeuchi; Hiroaki Itamochi
Journal:  J Gynecol Oncol       Date:  2017-07       Impact factor: 4.401

4.  Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study.

Authors:  Mustafa Erkan Sarı; Mehmet Mutlu Meydanlı; Osman Türkmen; Günsü Kimyon Cömert; Ahmet Taner Turan; Alper Karalök; Hanifi Şahin; Ali Haberal; Eda Kocaman; Özgür Akbayır; Baki Erdem; Ceyhun Numanoğlu; Kemal Güngördük; Muzaffer Sancı; Mehmet Gökçü; Nejat Özgül; Mehmet Coşkun Salman; Gökhan Boyraz; Kunter Yüce; Tayfun Güngör; Salih Taşkın; Duygun Altın; Uğur Fırat Ortaç; Hülya Aydın Ayık; Tayup Şimşek; Macit Arvas; Ali Ayhan
Journal:  J Gynecol Oncol       Date:  2017-07       Impact factor: 4.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.